- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Stanford Spinout TibaRay Opens Wefunder Campaign for FLASH Radiotherapy Tech
The company aims to enable ultrafast radiation delivery to reduce healthy tissue damage while maintaining tumor control.
Apr. 2, 2026 at 9:29pm
Got story updates? Submit your updates here. ›
TibaRay's innovative accelerator technology aims to revolutionize cancer treatment by enabling ultrafast radiation delivery that could significantly reduce side effects for patients.Stanford TodayTibaRay, a Stanford spinout, has launched a Regulation CF campaign on Wefunder to support the development of its next-generation accelerator technology designed to enable FLASH radiotherapy. The company's mission is to advance radiation therapy by delivering treatment hundreds of times faster than current systems, which research suggests may reduce damage to healthy tissue while maintaining tumor control.
Why it matters
FLASH radiotherapy is an emerging cancer treatment approach that could significantly improve outcomes for patients by minimizing side effects. TibaRay's proprietary accelerator technology is a key enabler for this new therapy, and the Wefunder campaign allows individual investors to participate in the company's efforts to commercialize this potentially transformative medical innovation.
The details
TibaRay has developed a proprietary linear accelerator called Galactica that has already been integrated into Leo Cancer Care's upright radiotherapy system. The company is pursuing a phased commercialization strategy, initially generating revenue by licensing its accelerator technology across medical and adjacent markets, with the long-term goal of deploying its PHASER radiotherapy system designed for ultrafast treatment delivery.
- TibaRay has launched its Regulation CF campaign on Wefunder in April 2026.
- To date, the company has received over $27 million in investment, including more than $14 million in non-dilutive federal research grants.
The players
TibaRay
A Stanford spinout company developing next-generation accelerator technology to enable FLASH radiotherapy, a cancer treatment approach that delivers radiation hundreds of times faster than current systems.
Leo Cancer Care
A medical technology company that has integrated TibaRay's Galactica linear accelerator into its upright radiotherapy system.
What’s next
The Wefunder campaign allows individual investors to participate in TibaRay's next phase of development as the company continues to advance its FLASH radiotherapy technology.
The takeaway
TibaRay's innovative accelerator technology has the potential to revolutionize cancer treatment by enabling ultrafast radiation delivery, which could significantly reduce side effects for patients while maintaining tumor control. The Wefunder campaign provides an opportunity for individual investors to support the development of this potentially transformative medical innovation.
